Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters











Database
Language
Publication year range
1.
Biotechnol Bioeng ; 107(2): 337-46, 2010 Oct 01.
Article in English | MEDLINE | ID: mdl-20506311

ABSTRACT

To enhance specific antibody (Ab) productivity (q(Ab)) of recombinant Chinese hamster ovary (rCHO) cells, post-translational limitations in the endoplasmic reticulum during antibody production should be relieved. Previously, we reported that overexpression of protein disulfide isomerase (PDI), which catalyzes disulfide bond exchanges and assists in protein folding of newly synthesized proteins, enhanced q(Ab) of rCHO cells by about 27% (Mohan et al., 2007, Biotechnol Bioeng 98:611-615) . Since the rate limiting step in disulfide bond formation is found to be the regeneration of oxidized PDI, the oxidation state of PDI, as well as the amount of PDI, might be important. Endoplasmic reticulum oxidoreductase (ERO1L) maintains PDI in an oxidized state so that disulfide bond formation occurs. Here, PDI and its helper protein, ERO1L were overexpressed in rCHO cells producing an Ab in an attempt to ease the bottleneck in disulfide bond formation, and hence, Ab folding and secretion. Transient expression of ERO1L alone and with PDI resulted in enhanced q(Ab) by 37% and 55%, respectively. In contrast, under stable inducible co-overexpression of PDI and ERO1L, the q(Ab) was unaffected or negatively affected by varying degrees, depending on the individual expression levels of these genes. In stable clones with altered oxidation state of PDI due to co-overexpression of PDI and ERO1L, secretion of Ab was hindered and PDI-associated retention of Ab was seen in the cells. Under transient gene expression, secretion of Ab was not compromised. The data presented here suggests a possible mechanism of PDI/ERO1L interaction with the target Ab and shows how the expression levels of these proteins could affect the q(Ab) of this Ab-producing rCHO cell line.


Subject(s)
Antibodies/metabolism , Endoplasmic Reticulum/enzymology , Gene Expression , Oxidoreductases/biosynthesis , Protein Disulfide-Isomerases/biosynthesis , Animals , CHO Cells , Cricetinae , Cricetulus , Disulfides/metabolism , Oxidation-Reduction , Recombinant Proteins/metabolism
2.
Biotechnol Bioeng ; 103(4): 757-66, 2009 Jul 01.
Article in English | MEDLINE | ID: mdl-19266576

ABSTRACT

Upon nutrient deprivation during culture, recombinant Chinese hamster ovary (rCHO) cells are subjected to two types of programmed cell death (PCD), apoptosis and autophagy. To investigate the effect of Bcl-x(L) overexpression on apoptosis and autophagy in rCHO cells, an erythropoietin (EPO)-producing rCHO cell line with regulated Bcl-x(L) overexpression (EPO-off-Bcl-x(L)) was established using the Tet-off system. The expression level of Bcl-x(L) in EPO-off-Bcl-x(L) cells was tightly regulated by doxycycline in a dose-dependent manner. Bcl-x(L) overexpression enhanced cell viability and extended culture longevity in batch culture. Upon nutrient depletion in the later stage of batch culture, Bcl-x(L) overexpression suppressed apoptosis by inhibiting the activation of caspase-3 and -7. Simultaneously, Bcl-x(L) overexpression also delayed autophagy, characterized by LC3-II accumulation. Immunoprecipitation analysis with a Flag-tagged Bcl-x(L) revealed that Bcl-x(L) interacts with Bax and Bak, essential mediators of caspase-dependent apoptosis, as well as with Beclin-1, an essential mediator of autophagy, and may inhibit their pro-cell death function. Taken together, it was found that Bcl-x(L) overexpression inhibits both apoptosis and autophagy in rCHO cell culture.


Subject(s)
Apoptosis , Autophagy , Culture Media/chemistry , bcl-2-Associated X Protein/biosynthesis , Animals , CHO Cells , Cell Culture Techniques , Cricetinae , Cricetulus , Gene Expression Regulation , bcl-2-Associated X Protein/genetics
3.
Cell Stress Chaperones ; 14(1): 49-60, 2009 Jan.
Article in English | MEDLINE | ID: mdl-18663604

ABSTRACT

Sodium butyrate (NaBu) can enhance the expression of foreign genes in recombinant Chinese hamster ovary (rCHO) cells, but it can also inhibit cell growth and induce cellular apoptosis. In this study, the potential role of calnexin (Cnx) expression in rCHO cells treated with 5 mM NaBu was investigated for rCHO cells producing tumor necrosis factor receptor FC. To regulate the Cnx expression level, a tetracycline-inducible system was used. Clones with different Cnx expression levels were selected and investigated. With regard to productivity per cell (q (p)), NaBu enhanced the q (p) by over twofold. Under NaBu treatment, Cnx overexpression further enhanced the q (p) by about 1.7-fold. However, under NaBu stress, the cells overexpressing Cnx showed a poorer viability profile with a consistent difference of over 25% in the viability when compared to the Cnx-repressed condition. This drop in the viability was attributed to increased apoptosis seen in these cells as evidenced by enhanced poly (ADP-ribose) polymerase cleavage and cytochrome C release. Ca(2+) localization staining and subsequent confocal imaging revealed elevated cytosolic Ca(2+) ([Ca(2+)](c)) in the Cnx-overexpressing cells when compared to the Cnx-repressed condition, thus endorsing the increased apoptosis observed in these cells. Taken together, Cnx overexpression not only improved the q (p) of cells treated with NaBu, but it also sensitized cells to apoptosis.


Subject(s)
Apoptosis/drug effects , Butyric Acid/pharmacology , Calnexin/metabolism , Animals , Blotting, Western , CHO Cells , Cell Count , Cell Survival/drug effects , Clone Cells , Cricetinae , Cricetulus , Doxorubicin/pharmacology , Gene Expression Regulation/drug effects , Microscopy, Confocal , Models, Biological , Receptors, Tumor Necrosis Factor/metabolism , Tetracycline/pharmacology
4.
Biotechnol J ; 3(5): 624-30, 2008 May.
Article in English | MEDLINE | ID: mdl-18293320

ABSTRACT

Recombinant glycoprotein therapeutics have proven to be invaluable pharmaceuticals for the treatment of various diseases. Chinese hamster ovary (CHO) cells are widely used in industry for the production of these proteins. Several strategies for engineering CHO cells for improved protein production have been tried with considerable results. The focus has mainly been to increase the specific productivity and to extend the culture longevity by preventing programmed cell death. These CHO cell engineering strategies, particularly those developed in Korea, are reviewed here.


Subject(s)
CHO Cells/physiology , Genetic Enhancement/methods , Protein Engineering/methods , Recombinant Proteins/biosynthesis , Technology Assessment, Biomedical , Animals , Cricetinae , Cricetulus
5.
Biotechnol Bioeng ; 98(3): 611-5, 2007 Oct 15.
Article in English | MEDLINE | ID: mdl-17421043

ABSTRACT

Protein disulfide isomerase (PDI), one of the ER-resident molecular chaperones, forms and isomerizes disulfide bonds. This study attempts to investigate the effect of PDI expression level on specific productivity (q) of recombinant Chinese hamster ovary (rCHO) cells producing thrombopoietin (TPO) and antibody (Ab). To regulate the PDI expression level, the Tet-Off system was introduced in TPO and Ab producing CHO cells, and stable Tet-Off cells (TPO-Tet-Off and Ab-Tet-Off) were screened using the luciferase assay. The doxycycline-regulated PDI expression system in Tet-Off rCHO cells (Tet-TPO-PDI and Tet-Ab-PDI) was established by the cotransfection of pTRE-PDI and pTK-Hyg expression vector into TPO-Tet-Off and Ab-Tet-Off cells, respectively. Subsequent screening was done by Western blot analysis of PDI and an enzyme-linked immunosorbent assay of the secreted TPO and antibody. We cultured two Tet-TPO-PDI and two Tet-Ab-PDI clones, and all these clones showed an average of 2.5-fold increase in PDI expression when compared to the basal level. In both these cell lines the PDI expression was tightly controlled by various concentrations of doxycycline. The q of TPO (q(TPO)) was unaffected but that of antibody producing cells was increased by 15-27% due to the PDI expression level.


Subject(s)
Antibodies, Monoclonal/metabolism , Doxycycline/administration & dosage , Protein Disulfide-Isomerases/metabolism , Protein Engineering/methods , Thrombopoietin/metabolism , Animals , Antibodies, Monoclonal/genetics , CHO Cells , Cricetinae , Cricetulus , Dose-Response Relationship, Drug , Gene Expression Regulation/drug effects , Gene Expression Regulation/physiology , Protein Disulfide-Isomerases/genetics , Recombinant Proteins/biosynthesis , Thrombopoietin/genetics
SELECTION OF CITATIONS
SEARCH DETAIL